In some ways, today may be a day looked back on as a turning point in medical history. Organovo (NASDAQ: ONVO), the first company to market 3D bioprinting technology, has announced the sale of its bioprinted livers, called the exVive3D™ Liver Model. Though too small to be considered an actual organ, the 3D printed exVive3D™ Liver Model has the potential to radically change the field of medicine.
Pioneer of the 3D bioprinting business Organovo has been researching the field since 2007, first developing their NovoGen MMX Bioprinter and then using their bioprinting process to begin 3D printing samples of living human tissue. After successfully creating a viable liver assay, the company announced that sometime in 2014, they would release their first product, a 3D printed liver for drug testing purposes.…
The original post The exVive3D™ Liver Model: Organovo Delivers its 3D Printed Livers appeared first on 3D Printing Industry.